We help innovative pharmaceutical companies and biotechs optimize the lifetime performance of their Intellectual property in the current environment of depleted R&D pipelines, cost containment and more aggressive generic competition.

Biotech & Pharma IP evaluation:

We offer the following interrelated services:

• Advice on setting up and implementing excellent lifecycle management (LCM) structures, systems and processes
• Training of project and brand teams in LCM
• Brand and project audits to ensure that LCM plans are comprehensive, realistic and sustainable
• Evaluation and valuation of individual patent portfolios, and advice on how to strengthen and / or prolong patent protection of brands

Our Experienced IPEG team members with a solid expertise in Pharma & Biotech Governance & Pharmaceutical Lifecycle Management:

Back to We do IP Advisory Work »